Literature DB >> 29412181

Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates.

Paolo Gaibani1, Simone Ambretti2, Maria Vittoria Tamburini2, Edoardo Vecchio Nepita2, Maria Carla Re3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29412181     DOI： 10.1016/j.jgar.2018.01.016

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN： 2213-7165            Impact factor:   4.035


× No keyword cloud information.
  3 in total

1.  Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia.

Authors:  Po-Hsin Kong; Cheng-Hsiung Chiang; Ting-Chia Lin; Shu-Chen Kuo; Chien-Feng Li; Chao A Hsiung; Yow-Ling Shiue; Hung-Yi Chiou; Li-Ching Wu; Hsiao-Hui Tsou
Journal:  Pathogens       Date:  2022-05-16

Review 2.  Susceptibility Testing of Bacteria Using Maldi-Tof Mass Spectrometry.

Authors:  Irene Burckhardt; Stefan Zimmermann
Journal:  Front Microbiol       Date:  2018-08-06       Impact factor: 5.640

3.  Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018.

Authors:  Paolo Gaibani; Donatella Lombardo; Linda Bussini; Federica Bovo; Beatrice Munari; Maddalena Giannella; Michele Bartoletti; Pierluigi Viale; Tiziana Lazzarotto; Simone Ambretti
Journal:  Antibiotics (Basel)       Date:  2021-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.